TrialBlood cancer journal2026

Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial.

Hao-Rui Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.